Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.

Joselle Cook,Kah Whye Peng,Susan Geyer,Brenda Ginos,Amylou C. Dueck,Nandakumar Packiriswamy,Lianwen Zhang,Beth Brunton,Baskar Balakrishnan,Thomas E. Witzig,Stephen M. Broski,Mrinal M Patnaik,Francis K. Buadi,Angela Dispenzieri,Morie A. Gertz,Leif Bergsagel,S. Vincent Rajkumar,Shaji Kumar,Stephen J. Russell,Martha Q. Lacy

Clinical activity of systemic VSV-IFNβ-NIS oncolytic virotherapy in patients with relapsed refractory T-cell lymphoma.

2021

2500Background: Oncolytic virotherapy is a novel immunomodulatory therapeutic approach for relapsed refractory hematologic malignancies. The Indiana strain of Vesicular Stomatitis Virus was enginee...

Keywords:

in patient
Therapeutic approach
Oncolytic virus
Cancer research
Medicine
Vesicular stomatitis virus
relapsed refractory
T-cell lymphoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations